What do lupus specialists believe about managing conventional cardiovascular risk factors in patients with systemic lupus erythematosus?

Manzi S , Meilahn EN , Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study . Am J Epidemiol 1997; 145: 408–415 .

Ward MM . Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus . Arthritis Rheum 1999; 42: 338–346 .

Bruce IN , Urowitz MB , Gladman DD , Hallett DC . Natural history of hypercholesterolemia in systemic lupus erythematosus . J Rheumatol 1999; 26: 2137–2143 .

Bessant R , Hingorani A , Patel L , MacGregor A , Isenberg DA , Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus . Rheumatology (Oxford)2004; 43: 924–929 .

Esdaile JM , Abrahamowicz M , Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus . Arthritis Rheum 2001; 44: 2331–2337 .

Hahn BH . Systemic lupus erythematosus and accelerated atherosclerosis . N Engl J Med 2003; 349: 2379–2380 .

Rahman P , Urowitz MB , Gladman DD , Bruce IN , Genest J Jr . Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus . J Rheumatol 1999; 26: 2363–2368 .

Wajed J , Ahmad Y , Durrington PN , Bruce IN . Prevention of cardiovascular disease in systemic lupus erythematosus–proposed guidelines for risk factor management . Rheumatology (Oxford) 2004; 43: 7–12 .

British Cardiac Society , British Hyperlipidaemia Association , British Hypertension Society , endorsed by the British Diabetic Association . Joint British recommendations on prevention of coronary heart disease in clinical practice . Heart 1998; 80 (Suppl 2): S1–S29 .

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) . Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) . JAMA 2001; 285: 2486–2497 .

Haffner SM , Lehto S , Ronnemaa T , Pyorala K , Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction . N Engl J Med 1998; 339: 229–234 .

Bruce IN , Urowitz MB , Gladman DD , Ibanez D , Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study . Arthritis Rheum 2003; 48: 3159–3167 .

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) . Lancet 1994; 344: 1383–1389 .

Downs JR , Clearfield M , Tyroler HA et al. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin . Am J Cardiol 2001; 87: 1074–1079 .

Petri M , Roubenoff R , Dallal GE , Nadeau MR , Selhub J , Rosenberg IH . Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus . Lancet 1996; 348: 1120–1124 .